Revvity, Inc. (NYSE:RVTY) Shares Bought by Ameriprise Financial Inc.

Ameriprise Financial Inc. lifted its position in Revvity, Inc. (NYSE:RVTY - Free Report) by 40.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 74,252 shares of the company's stock after purchasing an additional 21,380 shares during the period. Ameriprise Financial Inc. owned about 0.06% of Revvity worth $8,287,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in RVTY. T. Rowe Price Investment Management Inc. raised its position in Revvity by 16.7% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock worth $2,317,170,000 after acquiring an additional 2,969,326 shares during the period. Price T Rowe Associates Inc. MD raised its position in Revvity by 17.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock worth $851,764,000 after acquiring an additional 1,151,821 shares during the period. Norges Bank acquired a new position in Revvity during the fourth quarter worth $127,801,000. Invesco Ltd. raised its position in Revvity by 18.8% during the fourth quarter. Invesco Ltd. now owns 1,740,933 shares of the company's stock worth $194,306,000 after acquiring an additional 274,923 shares during the period. Finally, Proficio Capital Partners LLC raised its position in Revvity by 12,298.3% during the fourth quarter. Proficio Capital Partners LLC now owns 195,769 shares of the company's stock worth $21,850,000 after acquiring an additional 194,190 shares during the period. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms have weighed in on RVTY. Robert W. Baird reduced their price objective on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Barclays dropped their target price on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a report on Thursday, April 10th. Wells Fargo & Company dropped their target price on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating for the company in a report on Thursday, April 17th. Wall Street Zen lowered shares of Revvity from a "buy" rating to a "hold" rating in a report on Saturday. Finally, JPMorgan Chase & Co. dropped their target price on shares of Revvity from $120.00 to $100.00 and set a "neutral" rating for the company in a report on Tuesday, April 29th. Five research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $125.64.

Revvity Trading Down 1.1%

Shares of RVTY traded down $1.01 during mid-day trading on Monday, reaching $89.47. The stock had a trading volume of 1,023,503 shares, compared to its average volume of 951,592. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. Revvity, Inc. has a 52-week low of $88.01 and a 52-week high of $129.50. The business's fifty day moving average is $96.30 and its 200 day moving average is $108.88. The firm has a market cap of $10.55 billion, a price-to-earnings ratio of 40.48, a P/E/G ratio of 3.82 and a beta of 1.02.

Revvity (NYSE:RVTY - Get Free Report) last announced its earnings results on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.05. The company had revenue of $664.76 million during the quarter, compared to analyst estimates of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. Revvity's revenue was up 2.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.98 earnings per share. On average, sell-side analysts predict that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, July 18th. This represents a $0.28 annualized dividend and a dividend yield of 0.31%. Revvity's dividend payout ratio is presently 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.